当前位置: 首页 > 详情页

Risk factors for severe COVID-19 and development of a predictive model

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]North China Univ Sci & Technol, Affiliated Hosp, Tangshan, Hebei, Peoples R China [2]Fifth Hosp, Shijiazhuang, Hebei, Peoples R China [3]Hebei Key Lab Immune Mech Major Infect Dis & New T, Shijiazhuang, Peoples R China [4]First Peoples Hosp Zigong City, Zigong, Sichuan, Peoples R China [5]Xuanwu Hosp, Dept Resp & Crit Care Med, Xiongan, Peoples R China [6]Hebei Biol Cell Funct Dev & Precis Detect Technol, Dept Pathol, Tangshan, Hebei, Peoples R China [7]Tangshan Key Lab Precis Med Med Ind Integrat, Tangshan, Hebei, Peoples R China [8]Tangshan Innovat Technol Ctr Biol Cell Funct Dev &, Dept Pathol, Tangshan, Hebei, Peoples R China [9]Sun Guogui Innovat Studio, Tangshan, Hebei, Peoples R China
出处:
ISSN:

关键词: COVID-19 SARS-CoV-2 Predictive model Nomogram

摘要:
A clinical case-control study was conducted to identify risk factors for severe COVID-19 and to develop a predictive risk model to provide a reference for the dynamic assessment of the severity of disease in COVID-19 patients. A total of 410 patients with COVID-19 were included in the study, of whom 132 had severe or critical cases. The clinical data of the patients were collected, and the variables were subsequently screened via LASSO regression analysis and 10-fold cross-validation. The screened variables were subjected to multifactorial logistic regression analysis to screen out the independent risk factors for patients with severe or critical illnesses, and the independent risk factors were integrated to construct a nomogram. Model performance was evaluated using receiver operating characteristic (ROC) curve analysis, calibration curve analysis, and decision curve analysis (DCA), showing good predictive accuracy. Five variables, including the respiratory rate (R), systolic blood pressure (SBP), plasma albumin (ALB), lactate dehydrogenase (LDH), and C-reactive protein (CRP), were ultimately included to construct a clinical prediction model, with an area under the curve (AUC) of 0.86 (CI 0.82-0.90%). The clinical prediction model constructed in this study using simple clinical indicators can assist in the clinical prediction and identification of patients with heavy or critical COVID-19.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类 | 3 区 医学
小类 | 3 区 呼吸系统
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 呼吸系统
JCR分区:
出版当年[2023]版:
Q2 RESPIRATORY SYSTEM
最新[2024]版:
Q2 RESPIRATORY SYSTEM

影响因子: 最新[2024版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版] 出版后一年[2024版]

第一作者:
第一作者机构: [1]North China Univ Sci & Technol, Affiliated Hosp, Tangshan, Hebei, Peoples R China
通讯作者:
通讯机构: [1]North China Univ Sci & Technol, Affiliated Hosp, Tangshan, Hebei, Peoples R China [6]Hebei Biol Cell Funct Dev & Precis Detect Technol, Dept Pathol, Tangshan, Hebei, Peoples R China [7]Tangshan Key Lab Precis Med Med Ind Integrat, Tangshan, Hebei, Peoples R China [8]Tangshan Innovat Technol Ctr Biol Cell Funct Dev &, Dept Pathol, Tangshan, Hebei, Peoples R China [9]Sun Guogui Innovat Studio, Tangshan, Hebei, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:18237 今日访问量:0 总访问量:1002 更新日期:2025-11-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院